Cedars Sinai Health Ventures
Nonprofit profile at a glance
- EIN
- 883506667
- IRS 990 coverage
- 2022–2024
- Forms available
- Form 990 2024, Form 990-T 2024
- Location
- Los Angeles, CA, USA
- Phone
- 3104233277
- Rating confidence
- Limited
- Sector
- Single Organization Support
Reported finances
- Revenue
- $0
- Expenses
- $72,565
- Assets
- $34,603,886
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
5 people listed
Executive titles in this filing
- JAMES D LAUR (PRESIDENT/CEO & DIRECTOR)
Highest reported compensation
- SHLOMO MELMED (DIRECTOR): $3,872,673 total reported compensation
- DAVID M WRIGLEY (TREASURER AND DIRECTOR): $3,169,609 total reported compensation
- JAMES D LAUR (PRESIDENT/CEO & DIRECTOR): $1,864,150 total reported compensation
Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Cedars sinai health ventures ("cshv") is organized and operated exclusively for charitable purposes. Cshv's specific purpose is to support and benefit cedars-sinai medical center ("csmc") and(see schedule o for continuation)(continued)affiliates with tax-exempt status under section 501(c)(3) of the code that are hospital or clinics described in California health & safety code section 1206(l), through identification of, investment in, and deployment of health innovations that will support and enhance the quality and efficiency of health care delivery at cedars-sinai medical center and such affiliates.
What it reported doing in 2024
Cedars sinai health ventures is organized and operated exclusively for charitable purposes within the meaning of section 501(c)(3) of the internal revenue code.cshv's program services include the following activities:1) research companies, organizations and entities working on new medical technologies that are aimed at improving the provision of healthcare services by facilities such as csmc;2) provide funding to companies, organizations and entities working on new medical technologies that cshv believes will improve or otherwise assist in csmc's charitable activities, including the provision of healthcare services;(continued on schedule o)(continued)3) evaluate the potential for further development of the technologies and discoveries made by such companies, organizations or entities into products and services that could have a positive impact on illness or disease, unmet health needs, or healthcare delivery;4) support further development of the technology to create the potential for it to become a product or service benefiting the community as a whole;5) develop and maintain a network of researchers and technology professionals in academic institutions and industry that can collaborate to support early-stage discoveries made through the companies, organizations and entities cshv has made investments in;6) invest in and advise early-stage companies aimed at the manufacturing, production or sale of new medical technologies that cshv believes will improve or otherwise assist in csmc's charitable activities, including the provision of healthcare services; and7) manage the relationships with the companies, organizations and entities in cshv's investment portfolio.
Operating model
- Revenue model
- No positive adjusted resources. The filing reports no positive adjusted operating resources.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: 55
- Transparency & Controls: 67
- Accountability: 23
- Sustainability: 37
- Growth: 40
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: 72.7%; rating input score 73
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: 0 of 6 controls in place; rating input score 0
- Compensation committee: Missing
- Independent consultant: Missing
- Other Form 990s reviewed: Missing
- Written employment contract: Missing
- Compensation survey or study: Missing
- Board or committee approval: Missing
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Limited
- Related-party transparency: Yes; rating input score 100
Accountability
- Independent voting board: 0%; rating input score 0; 9th percentile among comparable filings
- Governance controls: 5 of 9 controls in place; rating input score 56
- Conflict-of-interest policy: Pass
- Whistleblower policy: Fail
- Document-retention policy: Fail
- CEO compensation review process: Fail
- Other executive compensation review process: Fail
- Form 990 shared with the board: Pass
- Board meeting minutes documented: Pass
- Audit committee oversight: Pass
- Independent financial-statement audit: Pass
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: 476.87; rating input score 98; 98th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 69; 69th percentile among comparable filings
- Officer compensation ratio: 2,324.3%; rating input score 1; 1st percentile among comparable filings
Growth
- Program expense growth: -141.9% per year; rating input score 0; 1st percentile among comparable filings
- Revenue growth: 0% per year; rating input score 100; 60th percentile among comparable filings
- Asset growth: -44.3% per year; rating input score 0; 3rd percentile among comparable filings
Details
- Where the money goes: 72.7% of spending went to programs
- Governance: 0 of 4 board members independent · 5 of 9 filing controls reported
- Programs: 1 filed program accomplishment · $53K in reported program spending
- Leadership: top reported pay $3.9M · 5 people listed · 0 of 6 pay-setting controls reported
- Consistency: 12 of 12 current checks pass
- Schedules: 5 filed schedules · includes executive pay and related organizations
- Filing history: 3 filing years from 2022 to 2024
- Contacts: How to reach this organization
- Related organizations: 26 filed related-organization links
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Accountability: Independent voting board scored 0/100.
- High — Transparency & Controls: Pay-setting controls scored 0/100.
- Review — Accountability: Governance controls: 4 of 9 not reported.
- High — Growth: Program expense growth scored 0/100.
- High — Sustainability: Officer compensation ratio scored 1/100.
- High — Growth: Asset growth scored 0/100.